Mucosal Vaccination with a Recombinant Salmonella typhimurium Expressing Human Papillomavirus Type 16 (HPV16) L1 Virus-like Particles (VLPs) or HPV16 VLPs Purified from Insect Cells Inhibits the Growth of HPV16-Expressing Tumor Cells in Mice
Véronique Revaz(Centre Hospitalier Universitaire Vaudois), Denise Nardelli‐Haefliger(University Hospital of Lausanne), P. De Grandi(Centre Hospitalier Universitaire Vaudois), Jalil Benyacoub(Centre Hospitalier Universitaire Vaudois), W. Martin Kast(University of Southern California), John T. Schiller(National Cancer Institute)
Cited by 51
Related Papers
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.
|The EMBO Journal|1989|930
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells
|Nature Medicine|2002|549